Cutler Group LP Kodiak Sciences Inc. Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$5.04 - $9.48 $5,544 - $10,428	-1,100 Reduced 64.71%	600 $0
Q1 2022 Apr 14, 2022	BUY	$7.09 - $89.45 $4,254 - $53,670	600 Added 54.55%	1,700 $2,000
Q4 2020 Jan 21, 2021	SELL	$60.78 - $154.03 $103,326 - $261,851	-1,700 Reduced 60.71%	1,100 $0
Q1 2020 May 07, 2020	BUY	$38.18 - $73.95 $106,904 - $207,060	2,800 New	2,800 $24,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.